本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cytek BioSciences

3.64
+0.04001.11%
盘后3.640.00000.00%18:04 EDT
成交量:154.86万
成交额:553.73万
市值:4.61亿
市盈率:-41.01
高:3.67
开:3.46
低:3.44
收:3.60
数据加载中...
2024/03/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/09

重要事件披露

Form 8-K - Current report
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]